Sanofi has returned to Nurix Therapeutics for another autoimmune candidate, paying $15 million and committing up to $465 million for exclusive rights to a degrader of a once-undruggable ...

Mad Square Box Office Day 8: Narne Nithin Claims Spot #5 For The Top Telugu Grossers Of The Year! ( Photo Credit – Instagram ) Check out the highest-grossing Telugu films of 2025 at the box office.

With such a performance, Mad Square earned a rocking 7.90 crore* net at the Indian box office on day 1, registering the 5th biggest start for Tollywood in 2025. Released in 2023, Mad earned 1.20 ...

Sanofi (NASDAQ:SNY) has agreed to acquire an immunology drug from clinical-stage biopharmaceutical company Dren Bio for up to $1.9B. The French pharmaceutical company will acquire DR-0201, a CD20 ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...

Comedy entertainer 'MAD Square' is exceeding expectations at the box office, crossing the $1 million mark in the USA and grossing over Rs 55.2 crore globally in three days. The film, directed by ...

The film notably bagged a spot in the top 5 Tollywood openers of 2025 and has continued to dominate the box office. According to Telugu FilmNagar reports, Mad Square has achieved impressive box ...

Sanofi SNY announced that it signed an agreement with California-based privately held biopharmaceutical company Dren Bio to acquire the latter’s investigational bispecific antibody DR-0201.

March 20 (Reuters) - Sanofi (SASY.PA), opens new tab on Thursday announced an agreement with biopharmaceutical company Dren Bio for the acquisition of its autoimmune disease treatment DR-0201.

Sanofi (Nasdaq: SNY) with We Are ILL, Inc., visits the Nasdaq MarketSite in Times Square. A patient advocacy organization, We Are ILL redefines what “sick” looks like by making the multiple ...

BRIDGEWATER, N.J., March 14, 2025 /PRNewswire/ -- Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the ...

Dren Bio deep B-cell depleter program has the potential to reset the immune system Acquisition underpins path for Sanofi becoming leading immunology company Sanofi to pay $600 million up front Paris, ...